Free Trial

CNS Pharmaceuticals (CNSP) Competitors

CNS Pharmaceuticals logo
$8.25 +0.20 (+2.48%)
Closing price 10/24/2025 03:51 PM Eastern
Extended Trading
$8.29 +0.04 (+0.48%)
As of 10/24/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNSP vs. PCSA, HOTH, EGRX, AIMD, LIXT, FNCH, MTEX, SYBX, LEXX, and EDSA

Should you be buying CNS Pharmaceuticals stock or one of its competitors? The main competitors of CNS Pharmaceuticals include Heatwurx (PCSA), Hoth Therapeutics (HOTH), Eagle Pharmaceuticals (EGRX), Ainos (AIMD), Lixte Biotechnology (LIXT), Finch Therapeutics Group (FNCH), Mannatech (MTEX), Synlogic (SYBX), Lexaria Bioscience (LEXX), and Edesa Biotech (EDSA). These companies are all part of the "pharmaceutical products" industry.

CNS Pharmaceuticals vs. Its Competitors

Heatwurx (NASDAQ:PCSA) and CNS Pharmaceuticals (NASDAQ:CNSP) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Heatwurx has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, CNS Pharmaceuticals has a beta of 2.68, suggesting that its share price is 168% more volatile than the S&P 500.

Heatwurx is trading at a lower price-to-earnings ratio than CNS Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HeatwurxN/AN/A-$11.85M-$2.32-0.13
CNS PharmaceuticalsN/AN/A-$14.86M-$3.75 thousand0.00

Heatwurx presently has a consensus price target of $1.00, indicating a potential upside of 222.37%. CNS Pharmaceuticals has a consensus price target of $20.00, indicating a potential upside of 142.42%. Given Heatwurx's higher probable upside, equities analysts clearly believe Heatwurx is more favorable than CNS Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heatwurx
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
CNS Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, CNS Pharmaceuticals had 2 more articles in the media than Heatwurx. MarketBeat recorded 3 mentions for CNS Pharmaceuticals and 1 mentions for Heatwurx. Heatwurx's average media sentiment score of 1.89 beat CNS Pharmaceuticals' score of 0.88 indicating that Heatwurx is being referred to more favorably in the media.

Company Overall Sentiment
Heatwurx Very Positive
CNS Pharmaceuticals Positive

CNS Pharmaceuticals' return on equity of -183.89% beat Heatwurx's return on equity.

Company Net Margins Return on Equity Return on Assets
HeatwurxN/A -342.36% -243.48%
CNS Pharmaceuticals N/A -183.89%-139.37%

91.9% of Heatwurx shares are held by institutional investors. Comparatively, 14.0% of CNS Pharmaceuticals shares are held by institutional investors. 2.4% of Heatwurx shares are held by company insiders. Comparatively, 0.1% of CNS Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

CNS Pharmaceuticals beats Heatwurx on 7 of the 13 factors compared between the two stocks.

Get CNS Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNSP vs. The Competition

MetricCNS PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.63M$3.43B$6.23B$10.66B
Dividend YieldN/A2.27%5.71%4.82%
P/E Ratio0.0024.2730.2930.24
Price / SalesN/A494.27591.44133.15
Price / CashN/A45.5737.0161.44
Price / Book0.1310.4012.046.60
Net Income-$14.86M-$52.62M$3.32B$276.82M
7 Day Performance-10.33%2.09%1.89%2.58%
1 Month Performance-4.62%12.32%7.68%3.76%
1 Year Performance-89.60%14.12%56.01%33.84%

CNS Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNSP
CNS Pharmaceuticals
2.4897 of 5 stars
$8.25
+2.5%
$20.00
+142.4%
-90.6%$4.63MN/A0.005News Coverage
Analyst Forecast
PCSA
Heatwurx
3.2007 of 5 stars
$0.39
-11.1%
$1.00
+155.1%
-76.1%$19.74MN/A-0.1720Positive News
Upcoming Earnings
HOTH
Hoth Therapeutics
2.5573 of 5 stars
$1.49
-2.9%
$4.50
+203.0%
+62.1%$19.69MN/A-1.394
EGRX
Eagle Pharmaceuticals
2.0698 of 5 stars
$1.50
-6.3%
N/AN/A$19.48M$257.55M0.00100
AIMD
Ainos
1.5265 of 5 stars
$3.94
flat
N/A+36.7%$18.79M$20K-0.7940Gap Up
LIXT
Lixte Biotechnology
0.1898 of 5 stars
$4.11
-5.3%
N/A+170.6%$18.74MN/A-3.194Gap Down
FNCH
Finch Therapeutics Group
1.6216 of 5 stars
$11.52
-5.2%
N/A+0.4%$18.50MN/A-1.31190High Trading Volume
MTEX
Mannatech
0.9972 of 5 stars
$9.73
-3.3%
N/A+21.5%$18.49M$117.87M-4.77250Gap Down
SYBX
Synlogic
1.7284 of 5 stars
$1.56
+0.4%
N/A+26.1%$18.21M$10K-19.4580Gap Up
LEXX
Lexaria Bioscience
3.0441 of 5 stars
$0.90
-0.4%
$4.00
+344.9%
-66.0%$17.58M$460K-1.347Positive News
EDSA
Edesa Biotech
1.9861 of 5 stars
$2.50
-1.8%
$5.00
+100.4%
-19.3%$17.57MN/A-1.8920News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:CNSP) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners